International Biotechnology Trust plc
Share this pagePrint this page

Portfolio Analysis

31 March 2014

Summary

 

IBT Portfolio NAV (m)

190

Number of Portfolio Companies

99

Quoted Investments

71

Unquoted Investments

28

 

Quoted / Unquoted Split
NAV by Geography

Quoted

87%

United States / Canada

91%

Unquoted

13%

Europe

9%

Total

100% 

Total

100%

 

 

 

 

 

NAV by Subsector
NAV by Market Capitalisation

 

 

Therapeutics

76%

Large-Cap (>$10bn)

48%

Medical Devices

4%

Mid-Cap (>$1bn, <$10bn)

29%

Specialty Pharma

11%

Small-Cap (<$1bn)

10%

Life Sciences, Tools

9%

Unquoted

12%

Total100%

Total

100%

 

 

NAV by Development Phase
NAV by Portfolio Profitability

 

 

 

Marketed

63%

Profitable

57%

Regulatory

8%

Turning Profitable 2014

10%

Phase 3

14%

Unprofitable

33%

Phase 2

9%

Total

100%

Phase 1

2%

 

Other

6%

 

Total

100%